Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Aliment Pharmacol Ther. 2010 Dec 29;33(5):559–565. doi: 10.1111/j.1365-2036.2010.04549.x

Table 2.

Adverse-effects on Therapy in Twenty Patients who Received Treatment

Adverse-effects N (%)

Constitutional 20 (100)
 Fatigue 19 (95)
 Fever or chills 17 (85)
 Myalgias 15 (75)
 Insomnia 12 (60)
 Anorexia 11 (55)
 Alopecia 8 (40)
 Headache 8 (40)
 Night sweats 6 (30)
 10% Weight loss 4 (20)

Psychiatric 18 (90)
 Irritability 15 (75)
 Depression/anxiety 12 (60)
 Despite SSRI prophylaxis 4 (20)
 Relapse of injection of illicit drug use 1 (5)

Hematologic 12 (60)
 Anemia 10 (50)
 Neutropenia 8 (40)

Autoimmune Diseases 5 (25)
 Papilitis 2 (10)
 Polymyalgia rheumatica 1 (5)
 Hypothyroidism 1 (5)
 Hyperthyroidism 1 (5)

Gastrointestinal 13 (65)
 Nausea 9 (45)
 Heartburn 5 (25)
 Right upper quadrant pain 3 (15)
 Pancreatitis 1 (5)

Dermatologic 8 (40)
 Itching 7 (35)
 Rash 4 (20)
Infection 3 (15)
 Urinary tract infection 2 (10)
 Upper respiratory tract infection 1 (5)
 Otitis media 1 (5)

Early Termination of Treatment due to Adverse Events 6 (30)